AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT04662736 — intervention group
Intervention type: OTHER
Intervention: patients having had a BJI/PJI treated with tedizolid as a suppressive antibiotic therapy
Description: description of osteo-articular infection managed with tedizolid as a suppressive antibiotic therapy
Study NCT04584333 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Brief intervention
Description: Group 1 (intervention group): depending on the willingness to change evaluated with the RCQ at each visit, the characteristics of the intervention to be performed will be established. Prochaska and DiClemente (1983) proposed a transtheoretical model of change in which different stages of change are identified that have been found to be predictive of adherence to treatment and its efficacy (Prochaska, Norcross and DiClemente, 1994). The RCQ includes three of the stages of change: Precontemplation, Contemplation and Action. In the Precontemplation stage, the person does not consider that he has a problem and has no intention of changing, in the Contemplation stage, he begins to contemplate that he has a problem and the possibility of change is raised and in the action stage, he has already started actively make a change in your behavior.
Study NCT02446379 — intervention group
Intervention type: DRUG
Intervention: The marketed product 2-5 MBq/kg 18F-fluorodeoxyglucose
Description: The FDG is injected at least 120 minutes prior to the imaging by the EnLightTM and LightPathTM Imaging Systems
Study NCT02446379 — intervention group
Intervention type: DEVICE
Intervention: EnLightTM
Description: The surgical cavity and the resected lymph nodes (if any) will be imaged by the EnLightTM system to establish whether radioactive tissue remains after surgery.
Study NCT02446379 — intervention group
Intervention type: DEVICE
Intervention: LightPathTM Imaging System
Description: The resected tumour excision specimens and the resected lymph nodes (if any)will be imaged by CLI and by WLI to establish whether they contain radioactive tissue.
Study NCT05912569 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Delay sentinel node biopsy
Description: In the case of a patient undergoing breast-conserving surgery for intraductal carcinoma, the sentinel lymph node is not excised during the primary surgery but only marked for identification. I
Study NCT05006417 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Botox
Description: reconstituted at 100 units/mL, dosage will be based upon the affected muscles
Study NCT06149143 — intervention group
Intervention type: DEVICE
Intervention: Cardiac Performance System (NSR)
Description: Participants will be asked to wear the Cardiac Performance System, a non-invasive sensor device on their upper abdomen. The Cardiac Performance System monitoring device will continuously monitor cardiac function.
Study NCT04372537 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: hypnosis
Description: use of hypnosis.
Study NCT04372537 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: standard care
Description: standard clinical procedure
Study NCT06370117 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Buzzy
Description: Before the procedure; 60 seconds before starting the vascular access process, the Buzzy® tool was placed in the procedure area and cold and vibration application was started. The tourniquet was tied 10-12 cm above the vein to be treated. The Buzzy® tool was fixed to the middle part of the procedure area and the tourniquet, approximately 2 cm above the IV catheter entry site.
Study NCT06370117 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Music video listening
Description: Before the procedure; A music video was played 60 seconds before starting the intravenous access procedure.
Study NCT06370117 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Buzzy+ Music video listening
Description: 60 seconds before starting the vascular access process, a music video was played and cold and vibration application was started with the Buzzy® tool. 60 seconds before the procedure began, the Buzzy® tool was placed on the procedure area and cold and vibration application was initiated. The tourniquet was tied 10-12 cm above the vein to be treated. The Buzzy® tool was fixed midway between the procedure area and the tourniquet, approximately 2 cm above the IV catheter entry site.
Study NCT04835233 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Methyldopa 250 MG
Description: maintaining postpartum the use of methyldopa 250 mg 01 tablet every 8 hours, being able to double the dose depending on pressure levels, up to 15 days postpartum
Study NCT04835233 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Methyldopa 250 MG
Description: maintaining postpartum the use of methyldopa 250 mg 01 tablet every 8 hours, being able to double the dose depending on pressure levels, up to 15 days postpartum
Study NCT05362513 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ivermectin Tablets
Description: Group B received a single dose of oral ivermectin 200 mcg per kg
Study NCT05362513 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Permethrin Cream
Description: Group A received Permethrin 5% twice with a one-week interval.
Study NCT05236140 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Perineal electrical stimulation
Description: Perineal electrical stimulation will be performed in lithotomy position via a stimulation device (Enraf Nonius Myomed 632) with perineal surface electrodes. Perineal electrical stimulation will be performed three days a week, 20 minutes a day, a total of 24 sessions for 8 weeks. The stimulation parameters are frequency at 50 Hz, a 5-10s work-rest cycle, and a 300ms pulse width. The symmetric biphasic pulse wave could be delivered over a range of 1-100mA (according to the patient's discomfort level feedback). In this application, three surface electrodes which had 2 cm diameters were used; two electrodes symmetrically at the perianal region (medial to ischial tuberosity); and one electrode at the leg (ground-neutral electrode). Surface electrodes will be used individually for each patient. Perineal electrical stimulation sessions will be performed by an experienced urogynecology rehabilitation nurse.
Study NCT05284734 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Regional anesthesia intervention
Description: Ultrasound-guided caudal and erector spinae blocks were administered
Study NCT05714475 — intervention group
Intervention type: PROCEDURE
Intervention: Pancreas surgery
Description: Criteria~Inclusion Criteria:~* Isolated pancreatic metastases from Colorectal cancer~* Previous surgery for colorectal cancer~* Surgically manageable lesions: duodenal-pancreatectomy surgical removal of metastatic repetitions in pancreas~pancreaticoduodenectomy total-pancreatectomy distal-pancreatectomy other metastases resection
Study NCT06432309 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Opicapone 50 mg
Description: Evaluate the addition of the COMT-I, Opicapone, to the Levodopa-Carbidopa intestinal gel in Parkinson's Disease patients with motor fluctuations.
Study NCT06432309 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Duodopa
Description: Evaluate Levodopa-Carbidopa intestinal gel in Parkinson's Disease patients with motor fluctuations.
Study NCT06432309 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Duodopa
Description: Evaluate Levodopa-Carbidopa intestinal gel in Parkinson's Disease patients with motor fluctuations.
Study NCT04220086 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Pediatric massage therapy
Description: Children with ASD will receive pediatric massage therapy twice a week for 12 consecutive weeks by professional pediatric massage doctor. In addition, they will receive parent provided pediatric massage therapy at home after their parents received the professional pediatric massage therapy training. The frequency of pediatric massage will not be more than once every day and each session last about 30 minutes.
Study NCT04220086 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Usual care
Description: Including Applied Behavior Analysis (ABA), Educational intervention, Interpersonal development intervention.
Study NCT04220086 — intervention group
Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: Usual care
Description: Including Applied Behavior Analysis (ABA), Educational intervention, Interpersonal development intervention.
Study NCT04220086 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: No intervention
Description: No intervention for healthy controls
Study NCT06176313 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mandala Group
Description: The Mandala activity lasts approximately 60 minutes.~• A calm environment is provided during the Mandala activity, and participants are ensured not to be disturbed by external stimuli or individuals unless they request assistance.~Each student's last menstrual date is recorded in an Excel table.~* Two days before the intervention day, students will be contacted and invited to participate in the study.~* Monitoring each student's menstrual cycle, the Mandala activity intervention is scheduled during the late luteal phase of each student's menstrual cycle. The intervention is planned within the 5 days before the expected start of menstrual bleeding on days and hours convenient for the student's class schedule.~* After each session, on the 4th day of the expected menstrual bleeding, students are subjected to PMSÖ.~* On the 4th day of the 4th menstrual period bleeding, the research will be concluded by applying the post-test with PMSÖ to the students.
Study NCT06176313 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Coping with Premenstrual Symptoms Education Group
Description: The education will be conducted through face-to-face interviews in the master's course classroom at the Faculty of Health Sciences at Bilecik Şeyh Edebali University. The education was conducted using PowerPoint presentations projected onto a white smartboard.~* One month after the completion of the education, a 1st Reminder training will be provided in the master's course classroom within the Faculty of Health Sciences at Bilecik Şeyh Edebali University, using the face-to-face interview method.~* One month after the 1st Reminder training, a 2nd Reminder training will be provided in the master's course classroom within the Faculty of Health Sciences at Bilecik Şeyh Edebali University, using the face-to-face interview method.~* On the 4th day of the 4th menstrual period bleeding, the research will be concluded by applying the post-test with PMSÖ to the students.
Study NCT06176313 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Control Group
Description: No intervention will be applied to the control group throughout the research. However, students in this group who cope with premenstrual syndrome using medication or non-medication methods will be monitored during the three-month menstrual cycle.~Each student's menstrual cycle in the control group has been recorded in the Excel table. The estimated end of menstruation for each student has been noted.~* At the estimated end of menstruation, the researcher contacts the students in the control group to inquire whether they have used any medication or non-medication methods to cope with premenstrual syndrome.~* Those who use medication or non-medication methods to reduce premenstrual symptoms are excluded from the study.~* On the 4th day of the 4th menstrual period bleeding, the post-test with PMSÖ will be applied to the students.
Study NCT04662255 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pirtobrutinib
Description: Oral
Study NCT04662255 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ibrutinib
Description: Oral
Study NCT04662255 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Acalabrutinib
Description: Oral
Study NCT04662255 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Zanubrutinib
Description: Oral
Study NCT05995249 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TAK-279
Description: TAK-279 capsules
Study NCT05995249 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Erythromycin
Description: Erythromycin tablets
Study NCT05995249 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Phenytoin
Description: Phenytoin capsules
Study NCT05995249 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efavirenz
Description: Efavirenz tablets
Study NCT06347445 — intervention group
Intervention type: OTHER
Intervention: There is no intervention.
Description: There is no intervention.
Study NCT05952713 — intervention group
Intervention type: DRUG
Intervention: Antidepressant
Description: Treatment with an antidepressant according to Danish register data.
Study NCT05541900 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: TEC-Sacredness
Description: The participant is asked to identify and select the correct match on each trial as quickly as possible. Match pairs (i.e., a self-related word paired with a life-related stimulus, a sacredness of life-related stimulus paired with a pleasant stimulus, and a neutral stimulus paired with a neutral stimulus) are first presented to the participant. A grid is then shown containing one of the match pairs along with distraction stimuli.
Study NCT05541900 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: TEC-Control
Description: The participant is asked to identify and select the correct match on each trial as quickly as possible. Match pairs (i.e., a neutral stimulus paired with a neutral stimulus) are first presented to the participant. A grid is then shown containing one of the match pairs along with distraction stimuli.
Study NCT05866549 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mindfulness-based Childbirth and Parenting Program
Description: Mindfulness-based childbirth and parenting program will be applied to individuals in this group. The program consists of nine sessions, eight of which will take place during pregnancy. Sessions planned during pregnancy will be held once a week, lasting 8 weeks.
Study NCT05370508 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: SONALA-001 (ALA) and MR-Guided Focused Ultrasound device (MRgFUS)
Description: SONALA-001(ALA) given 6-12 hours prior to receiving the MRgFUS
Study NCT06401343 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Empagliflozin 10 MG
Description: Participants randomized to the study group will received Empagliflozin 10mg q.d. for 12 months.
Study NCT05823467 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TMP-SMX DS
Description: Oral Antibiotic - used to treat post operative wound infections.
Study NCT05823467 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: ciNPT dressing
Description: Negative pressure wound VAC placed on incision post operatively.
Study NCT04842799 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Digital Delivery of Pre-Genetic Testing Information via the BRCA-DIRECT Platform
Description: Participants will receive a link to the digital pre-test information. This will consist of text covering: Genetics and cancer risk; Genetics testing; What will happen if your test is positive; What will happen if your test is negative; Implications for insurance.~Where relevant, parts of the text will be linked through to additional information, such as insurance advice from the Association of British Insurers. Participants will be able to call a genetic counsellor on the hotline during weekday office hours, should they have any questions or require further information.
Study NCT04842799 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Digital Delivery of Genetic Test Results via the BRCA-DIRECT Platform
Description: Participants will receive a digital message that their results are available. When they click this, they will receive digital notification of their negative (normal) result in short form. Full details will be provided in an individualised letter.
Study NCT05338541 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tucidinostat and etoposide
Description: Tucidinostat: 3+3 design，14 mg/m2，17.5 mg/m2，23 mg/m2 etoposide: 50mg/m2,
Study NCT05635955 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Remimazolam
Description: Total intravenous anaesthesia will be induced with 0.3mg/kg remimazolam and 0.3mg/kg esketamine, slow injection.~During the painless abortion surgery, if the MOAA/S scores > 1 or body movements occur, supplemental 0.2 mg/kg remimazolam (IV) will be administrated.
Study NCT05635955 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Propofol
Description: Total intravenous anaesthesia will be induced with 2mg/kg propofol and 0.3mg/kg esketamine, slow injection.~During the painless abortion surgery, if the MOAA/S scores > 1 or body movements occur, supplemental 0.25 mg/kg propofol (IV) will be administrated.
Study NCT05635955 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Esketamine
Description: 0.3mg/kg esketamine will be co-administrated in both arms
Study NCT05635955 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Esketamine
Description: 0.3mg/kg esketamine will be co-administrated in both arms
Study NCT05367752 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Myofascial release with TENS conductive glove
Description: Before each MR session, light massage and stretching was applied for five minutes as preparation for the manipulations. The massage included the effleurage technique followed by petrissage and kneading on the cervical and thoracic areas (on the upper three parts of the trapezius muscle, in the suboccipital area, and on the paraspinal cervical muscles). Stretching was applied to the following muscles: upper part of the trapezius, levator scapulae, and the sternocleidomastoid muscle.~Upper trapezius myofascial release, unilateral gross stretch, vertical gross stretch, focused stretch, cranial base myofascial release, gross release of the sternocleidomastoid muscle, and release of the suprahyoid and infrahyoid muscles.
Study NCT05367752 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Myofascial release without TENS conductive glove
Description: Before each MR session, light massage and stretching was applied for five minutes as preparation for the manipulations. The massage included the effleurage technique followed by petrissage and kneading on the cervical and thoracic areas (on the upper three parts of the trapezius muscle, in the suboccipital area, and on the paraspinal cervical muscles). Stretching was applied to the following muscles: upper part of the trapezius, levator scapulae, and the sternocleidomastoid muscle.~Upper trapezius myofascial release, unilateral gross stretch, vertical gross stretch, focused stretch, cranial base myofascial release, gross release of the sternocleidomastoid muscle, and release of the suprahyoid and infrahyoid muscles.
Study NCT05367752 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Conventional TENS
Description: Two 40\*50mm silicone electrodes were placed with the negative electrode on the trigger point of the trapezius muscle and the positive one on the acromion. The current frequency was 120Hz and pulse duration 80ms for 30 minutes. This protocol has been proposed by Ebadi et al. (2021)
Study NCT05367752 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Sham TENS
Description: Two 40\*50mm silicone electrodes were placed with the negative electrode on the trigger point of the trapezius muscle and the positive one on the acromion. The current frequency was 120Hz and pulse duration 80ms for 30 minutes. This protocol has been proposed by Ebadi et al. (2021)
Study NCT05229341 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Diagnostic Procedure
Description: Analysis via DDMS-2
Study NCT05229341 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Electronic Health Record Review
Description: Review of medical records
Study NCT05229341 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Needle Biopsy
Description: Undergo needle biopsy
Study NCT04077775 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: assesment
Description: assesment
Study NCT05394389 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: sensory stimulating therapy
Description: therapy session in the snoozlen room accompanied by social support.
Study NCT05394389 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: sensory stimulating therapy
Description: therapy session in the snoozlen room accompanied by social support.
Study NCT05394389 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: social support
Description: ten minutes of conversing.
Study NCT05394389 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: social support
Description: ten minutes of conversing.
Study NCT05736302 — intervention group
Intervention type: OTHER
Intervention: Doubly-Labeled Water
Description: All eligible participants will receive a dose of doubly-labeled water.
Study NCT05425173 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Conventional treatment
Description: Chest Physical Therapy as required
Study NCT05425173 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Limb Range of Motion Exercises + Chest Physical Therapy
Description: Limb Range of Motion Exercises + Chest Physical Therapy~Frequency: 4 sessions Time: 5 to 10 minutes
Study NCT06354192 — intervention group
Intervention type: BEHAVIORAL
Intervention: Precision Nudging for Hypertension Management
Description: The hypertension digital health intervention under study combines behavioral science theory with a type of machine learning called reinforcement learning to enable precision nudging: the selection, assembly, and delivery of behavioral science-based messages created to address barriers to, and promote, management of hypertension. The behavioral design process used for the hypertension DHI intentionally includes research on traditionally underserved populations, such as racial and ethnic minorities and people with lower incomes or educational attainment. By including the right ingredients to meet a diverse set of needs and by effectively personalizing the content each individual sees based on their own reactions, the intervention aims to improve health equity by matching each individual to the right behavioral approach.